[go: up one dir, main page]

DK0844241T3 - Inhibitor af narkotisk analgetisk afhængighed/resistensudvikling - Google Patents

Inhibitor af narkotisk analgetisk afhængighed/resistensudvikling

Info

Publication number
DK0844241T3
DK0844241T3 DK96926004T DK96926004T DK0844241T3 DK 0844241 T3 DK0844241 T3 DK 0844241T3 DK 96926004 T DK96926004 T DK 96926004T DK 96926004 T DK96926004 T DK 96926004T DK 0844241 T3 DK0844241 T3 DK 0844241T3
Authority
DK
Denmark
Prior art keywords
narcotic analgesic
inhibitor
resistance development
development
substituted
Prior art date
Application number
DK96926004T
Other languages
English (en)
Inventor
Tadashi Shiotani
Toshitaka Nabeshima
Mitsunobu Yoshii
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Application granted granted Critical
Publication of DK0844241T3 publication Critical patent/DK0844241T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/402—1-aryl substituted, e.g. piretanide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK96926004T 1995-08-07 1996-08-06 Inhibitor af narkotisk analgetisk afhængighed/resistensudvikling DK0844241T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20076395 1995-08-07
PCT/JP1996/002207 WO1997006139A1 (fr) 1995-08-07 1996-08-06 Inhibiteur de la dependance / de la resistance a l'egard des analgesiques narcotiques

Publications (1)

Publication Number Publication Date
DK0844241T3 true DK0844241T3 (da) 2003-05-12

Family

ID=16429771

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96926004T DK0844241T3 (da) 1995-08-07 1996-08-06 Inhibitor af narkotisk analgetisk afhængighed/resistensudvikling

Country Status (13)

Country Link
US (1) US6107330A (da)
EP (1) EP0844241B1 (da)
KR (1) KR19990036248A (da)
CN (1) CN1085979C (da)
AT (1) ATE231491T1 (da)
AU (1) AU6631396A (da)
CA (1) CA2228813A1 (da)
DE (1) DE69625913T2 (da)
DK (1) DK0844241T3 (da)
ES (1) ES2191763T3 (da)
NO (1) NO315078B1 (da)
TW (1) TW457087B (da)
WO (1) WO1997006139A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0953356A4 (en) * 1996-10-01 2002-04-17 Daiichi Seiyaku Co MITOCHONDRIAL MEMBRANE STABILIZER
EP1020189B1 (en) * 1997-07-15 2004-05-12 Daiichi Pharmaceutical Co., Ltd. Nefiracetam for prevention and treatment of amnesia caused by propofol
US6890951B2 (en) 1998-08-05 2005-05-10 Brookhaven Science Associates Llc Treatment of addiction and addiction-related behavior
US20040077709A1 (en) * 1999-05-31 2004-04-22 Daiichi Pharmaceutical Co., Ltd. Neuronal death inhibitors
US6423739B1 (en) 2000-02-23 2002-07-23 Daiichi Pharmaceutical Co., Ltd. Method for aiding cerebral recovery following neurodegeneration
US6348489B1 (en) 2000-04-11 2002-02-19 Daiichi Pharmaceutical Co., Ltd. Method of treating traumatic brain injury and other neuronal disorders
KR100823668B1 (ko) * 2000-12-28 2008-04-21 해밀턴 파마슈티컬스 인코포레이티드 신경성 통증 치료 및 예방약
JP4505410B2 (ja) 2002-10-29 2010-07-21 サングキュンクワン ユニヴァースィティ モルヒネへの心理的依存又は耐性を防止及び処置するのに有効成分としてベルベリンを含有する医薬組成物
US20060241144A1 (en) * 2005-04-20 2006-10-26 Albert Cha Method for treating apathy syndrome

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5198317A (en) * 1975-02-21 1976-08-30 22 okisopirorijin 11 iruasetamidochushaekinoseizoho
US4212878A (en) * 1978-01-26 1980-07-15 The Upjohn Company Phenylacetamide derivative analgesics
IT1141287B (it) * 1979-06-13 1986-10-01 Nattermann A & Cie Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici,procedimento per la loro preparazione e prodotti medicinali che le contengono
US4490167A (en) * 1979-08-06 1984-12-25 Ciba-Geigy Corporation Oxime derivatives of diphenyl ethers and their use in herbicidal compositions
BE893276A (fr) * 1981-06-01 1982-11-24 Sandoz Sa Nouvelle application therapeutique d'un derive de l'acetamide
US5468749A (en) * 1988-08-30 1995-11-21 Gawin; Frank H. Method for treatment of substance addiction
US5185329A (en) * 1988-08-30 1993-02-09 Bristol-Myers Squibb Company Method for treatment of substance addiction
IL91451A0 (en) * 1988-08-30 1990-04-29 Bristol Myers Co Pharmaceutical compositions comprising azapiron compounds and their use in the treatment of addiction
DE415693T1 (de) * 1989-08-28 1991-10-17 Arizona Technology Development Corp., Tucson, Ariz. Zusammensetzung und verfahren zur selektiven verstaerkung der opiat-wirkung und verminderung von opiat-toleranz und abhaengigkeit.
US5220018A (en) * 1991-04-10 1993-06-15 Merck & Co., Inc. Cholecystokinin antagonists
IL101514A (en) * 1991-04-10 1996-01-31 Merck & Co Inc Benzodiazepinone derivatives and cholecystokinin antagonist pharmaceutical compositions containing them
JPH0517421A (ja) * 1991-07-10 1993-01-26 Yamanouchi Pharmaceut Co Ltd Ｎ−置換アミド誘導体
CA2098663A1 (en) * 1992-06-19 1993-12-20 Shinji Kamihara Process for preparing pyrrolidinylacetamide derivative
US5461157A (en) * 1992-06-19 1995-10-24 Daiichi Pharmaceutical Co., Ltd. Process for preparing pyrrolidinylacetamide derivatives

Also Published As

Publication number Publication date
US6107330A (en) 2000-08-22
CN1085979C (zh) 2002-06-05
DE69625913T2 (de) 2003-11-27
KR19990036248A (ko) 1999-05-25
NO980531D0 (no) 1998-02-06
WO1997006139A1 (fr) 1997-02-20
DE69625913D1 (de) 2003-02-27
ES2191763T3 (es) 2003-09-16
CN1198738A (zh) 1998-11-11
AU6631396A (en) 1997-03-05
NO980531L (no) 1998-04-06
ATE231491T1 (de) 2003-02-15
EP0844241A4 (en) 1998-11-18
EP0844241A1 (en) 1998-05-27
TW457087B (en) 2001-10-01
CA2228813A1 (en) 1997-02-20
EP0844241B1 (en) 2003-01-22
NO315078B1 (no) 2003-07-07

Similar Documents

Publication Publication Date Title
EP1072263A4 (en) AMID DERIVATIVES AND NOCICEPTINANT AGONISTS
DE60236117D1 (de) Phosphattransporthemmer
ECSP034564A (es) Composicion pesticida
DK0539117T3 (da) Forbindelser, der er nyttige som leukotrien-antagonister
CY1111951T1 (el) Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου
DK0652005T3 (da) Fremgangsmåder til inhibering af endometriose
PT842923E (pt) Derivados do pirrolo e composicoes medicinais
ES2126075T3 (es) Derivados biciclicos nitrogenados como inhibidores de la propil-endopeptidasa.
EP1314719A4 (en) BENZOIC ACID DERIVATIVES AND MEDICAMENTS HAVING THE SAME AS ACTIVE INGREDIENT
DE69104615D1 (de) Diphenylpiperazinderivat.
DK0844241T3 (da) Inhibitor af narkotisk analgetisk afhængighed/resistensudvikling
ES2093091T3 (es) Derivado de glutation.
DE69825977D1 (de) Antivirale mittel
MX9206930A (es) Nuevos compuestos
EA199900888A1 (ru) Противоревматические средства
EA200000681A1 (ru) Фунгицидная смесь на базе амидных соединений и производных пиридина
ES2078651T3 (es) Compuesto de piridinsulfonamida sustituida o una sal del mismo, procedimiento para su preparacion y herbicida que lo contiene.
DK0653207T3 (da) Sammensætning til hæmning af AIDS-virus-infektion
EA200400371A1 (ru) Фунгицидные смеси
EP1306378A4 (en) DRUGS AGAINST DEMENTIA CONTAINING 2-ARYL-8-OXODIHYDROPURINE DERIVATIVES AS AN ACTIVE INGREDIENT
EP1270561A4 (en) INHIBITOR OF THE BRASSINOSTEROID'S BIOSYNTHESIS
DK0777471T3 (da) Inhibering af leukotrienbiosynese med urinstofderivater
EP0811620A4 (en) PHENYLAMIDINOTHIOPHENE DERIVATIVES AND ANTIPHLOGISTIC AGENT CONTAINING THEM
TR28240A (tr) Amidotiofosfat türevi ve aktif engrediyan olarak bunu iceren insektisid, nematosid ve akarisid.